The James Webb Space Telescope captured amazing imagery of merging galaxies II ZW 96. The merger is located 500 million light ...

An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient characteristics ...

Japan: Researchers have found in a new study that Roxadustat therapy in non-dialyzed chronic kidney disease (CKD) patients may lead to hemoglobin (Hb) overshoot, particularly when switching ...

During a live event, Thomas LeBlanc, MD, MA, discussed dose escalation of luspatercept in myelodysplastic syndromes and ...

Music star Lizzo has revealed the secrets to her recent weight loss.

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

Reblozyl was found to be superior to standard ESA therapy with Amgen and Johnson & Johnson's Epogen/Procrit (epoetin alfa) at achieving those objectives, with almost 59% of patients on BMS' drug ...

In the program’s first three years, families who make under 300% of the federal poverty level can qualify for an education savings account. For a household of four, that’s about $93,600. In Alabama, ...

RS offers Belden's extensive Alpha Wire portfolio of high-performance, purpose-driven industrial automation cables ...

Erythropoiesis-stimulating agents (ESA), supplemented by iron therapy, are used to treat anaemia in chronic kidney disease and cancer, however safety concerns have been raised in these patients. The ...

ESA is moving ahead with plans for the first phase of an Earth observation satellite system that will have both civil and military uses.